Position in PROK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$22,090,866
-$5,553,569 QoQ
Shares Held
12,341,266
0.0% QoQ
Ownership
4.09%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PROK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUVRETTA CAPITAL MANAGEMENT, LLC holds $2,459,096,047 across 36 Biotechnology names. PROK ranks #25 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
12,327,000 | $290,424,120 | |
| 2 | MANE |
Veradermics, Inc
|
4,168,970 | $263,270,455 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
|
1,153,496 | $143,783,276 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
3,518,471 | $141,548,088 | |
| 5 | LEGN |
Legend Biotech Corp
|
7,581,029 | $137,140,814 | |
| 6 | BNTC |
Benitec Biopharma Inc.
|
11,548,351 | $122,989,938 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
3,818,600 | $116,085,440 | |
| 8 | IMTX |
Immatics N.V.
|
11,190,129 | $110,110,869 |
All Filings in PROK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,090,866 | 12,341,266 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,644,435 | 12,341,266 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,865,863 | 12,341,266 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||